IL326478A - אוליגונוקלאוטידים לאפנון של ביטוי kcnt1 - Google Patents
אוליגונוקלאוטידים לאפנון של ביטוי kcnt1Info
- Publication number
- IL326478A IL326478A IL326478A IL32647826A IL326478A IL 326478 A IL326478 A IL 326478A IL 326478 A IL326478 A IL 326478A IL 32647826 A IL32647826 A IL 32647826A IL 326478 A IL326478 A IL 326478A
- Authority
- IL
- Israel
- Prior art keywords
- kcnt1
- oligonucleotides
- modulating
- expression
- modulating kcnt1
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/712—Nucleic acids or oligonucleotides having modified sugars, i.e. other than ribose or 2'-deoxyribose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/321—2'-O-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/33—Chemical structure of the base
- C12N2310/334—Modified C
- C12N2310/3341—5-Methylcytosine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/34—Spatial arrangement of the modifications
- C12N2310/341—Gapmers, i.e. of the type ===---===
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/34—Spatial arrangement of the modifications
- C12N2310/346—Spatial arrangement of the modifications having a combination of backbone and sugar modifications
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP23306381 | 2023-08-16 | ||
| PCT/EP2024/072847 WO2025036916A1 (en) | 2023-08-16 | 2024-08-14 | Oligonucleotides for modulating kcnt1 expression |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL326478A true IL326478A (he) | 2026-04-01 |
Family
ID=88016605
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL326478A IL326478A (he) | 2023-08-16 | 2024-08-14 | אוליגונוקלאוטידים לאפנון של ביטוי kcnt1 |
Country Status (6)
| Country | Link |
|---|---|
| AR (1) | AR133556A1 (he) |
| AU (1) | AU2024323589A1 (he) |
| CO (1) | CO2026001780A2 (he) |
| IL (1) | IL326478A (he) |
| MX (1) | MX2026001759A (he) |
| WO (1) | WO2025036916A1 (he) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69233046T2 (de) | 1991-10-24 | 2004-03-04 | Isis Pharmaceuticals, Inc., Carlsfeld | Derivatisierte oligonukleotide mit verbessertem aufnahmevermögen |
| WO2013033230A1 (en) | 2011-08-29 | 2013-03-07 | Isis Pharmaceuticals, Inc. | Oligomer-conjugate complexes and their use |
| CN104837996A (zh) | 2012-11-15 | 2015-08-12 | 罗氏创新中心哥本哈根有限公司 | 抗apob反义缀合物化合物 |
| DK2992098T3 (da) | 2013-05-01 | 2019-06-17 | Ionis Pharmaceuticals Inc | Sammensætninger og fremgangsmåder til modulering af hbv- og ttr-ekspression |
| HUE048738T2 (hu) | 2013-06-27 | 2020-08-28 | Roche Innovation Ct Copenhagen As | Antiszensz oligomerek és konjugátumok, amelyek a PCK9-t célozzák meg |
| IL320434A (he) | 2015-07-22 | 2025-06-01 | Wave Life Sciences Ltd | תכשירים של אוליגונוקליאוטידים ושיטות |
| CR20210519A (es) * | 2019-03-15 | 2021-11-24 | Ionis Pharmaceuticals Inc | Compuestos y métodos para reducir la expresión de kcnt1 |
| US11629347B2 (en) | 2019-05-06 | 2023-04-18 | University Of Massachusetts | Anti-C9ORF72 oligonucleotides and related methods |
| AU2022213384A1 (en) * | 2021-01-29 | 2023-07-20 | Ionis Pharmaceuticals, Inc. | Compounds and methods for modulating huntingtin |
-
2024
- 2024-08-14 IL IL326478A patent/IL326478A/he unknown
- 2024-08-14 AU AU2024323589A patent/AU2024323589A1/en active Pending
- 2024-08-14 WO PCT/EP2024/072847 patent/WO2025036916A1/en active Pending
- 2024-08-15 AR ARP240102163A patent/AR133556A1/es unknown
-
2026
- 2026-02-12 MX MX2026001759A patent/MX2026001759A/es unknown
- 2026-02-16 CO CONC2026/0001780A patent/CO2026001780A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR133556A1 (es) | 2025-10-08 |
| AU2024323589A1 (en) | 2026-03-05 |
| TW202515583A (zh) | 2025-04-16 |
| CO2026001780A2 (es) | 2026-03-05 |
| WO2025036916A1 (en) | 2025-02-20 |
| MX2026001759A (es) | 2026-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202007542B (en) | Oligonucleotides for modulating scn9a expression | |
| IL296413B2 (he) | תרכובות מאפנן gpr52 | |
| IL276357A (he) | אוליגונוקליאוטידים לאפנון ביטוי tmem106b | |
| IL279929A (he) | אוליגונוקליאוטידים לאפנון ביטוי rtel1 | |
| IL315749A (he) | אוליגונוקליאוטידים שעברו שינוי | |
| EP4081302A4 (en) | OLIGONUCLEOTIDES FOR TISSUE-SPECIFIC GENE EXPRESSION MODULATION | |
| IL318189A (he) | מאפנני rbm39 הטרוציקליים | |
| SMT202500449T1 (it) | Composti modulatori di gpr52 | |
| IL301007B1 (he) | תרכובות מאפנני gpr52 | |
| IL326478A (he) | אוליגונוקלאוטידים לאפנון של ביטוי kcnt1 | |
| GB202302629D0 (en) | MC2R modulator compounds | |
| GB202302618D0 (en) | MC2R modulator compounds | |
| CA3301633A1 (en) | Oligonucleotides for modulating kcnt1 expression | |
| CA3281435A1 (en) | Oligonucleotides for modulating synaptogyrin-3 expression | |
| EP4320237A4 (en) | OLIGONUCLEOTIDES | |
| GB202319945D0 (en) | MC2R modulator compounds | |
| GB202313601D0 (en) | MC2R modulator compounds | |
| GB202308196D0 (en) | Mc2r Modulator compounds | |
| GB202302630D0 (en) | Mc2r modulator compounds | |
| GB202202480D0 (en) | MC2R modulator compounds | |
| GB202202483D0 (en) | MC2R modulator compounds | |
| GB202202479D0 (en) | MC2R modulator compounds | |
| CA232226S (en) | Applicator for implants | |
| IL320604A (he) | שיטות למודולציה של ביטוי של גורם משלים b | |
| IL299269A (he) | אוליגונוקליאוטידים משופרים לאפנון ביטוי fubp1 |